Spots Global Cancer Trial Database for A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Official Title: A Long-Term Follow-up Study for Subjects Previously Treated With A Century Therapeutics Cellular Therapy Product
Study ID: NCT05768269
Interventions
Study Description
Brief Summary: This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Levine Cancer Institute, Charlotte, North Carolina, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Swedish Cancer Institute, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
